Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17521815 | 0.80 | DPP4 (0.37) | KDM4ENPC1ALDH1A1RAB9AMAOA | |
| SCHEMBL17521802 | 0.75 | MAOB (0.38) | KDM4ENPC1ALDH1A1RAB9AMAOA | |
| SCHEMBL17521826 | 0.75 | DPP4 (0.39) | KDM4ENPC1ALDH1A1RAB9AMAOA | |
| SCHEMBL17521804 | 0.75 | CYP1B1 (0.54) | NPC1ALDH1A1RAB9ACYP1A1CYP1A2 | |
| SCHEMBL15024908 | 0.70 | ALDH1A1 (0.35) | KDM4EALDH1A1DPP4 | |
| SCHEMBL12964717 | 0.70 | LTA4H (0.50) | KDM4ENPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL15180626 | 0.69 | DPP4 (0.35) | KDM4ENPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL12964715 | 0.69 | DPP4 (0.52) | KDM4ENPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL18674375 | 0.66 | GRM5 (0.38) | KDM4EALDH1A1RAB9ASMN1; SMN2DPP4 | |
| SCHEMBL17521791 | 0.66 | ALDH1A1 (0.40) | KDM4ENPC1ALDH1A1RAB9AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9512131-B2 | Organic semiconductor material for organic transistor, and organic transistor element | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2016-12-06 | — | — | US | disclosed |
| US-20160049594-A1 | ORGANIC SEMICONDUCTOR MATERIAL FOR ORGANIC TRANSISTOR, AND ORGANIC TRANSISTOR ELEMENT | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2016-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160049594-A1 | ORGANIC SEMICONDUCTOR MATERIAL FOR ORGANIC TRANSISTOR, AND ORGANIC TRANSISTOR ELEMENT | SLC43A1, ALKBH3, TPR | KDM4E 1037/4885NPC1 3362/4885ALDH1A1 2876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.